The altered PC/LPC ratio also suggests a potential role of the lecithin-cholestrol acyltransferase and/or phospholipase A2 (Lp-PLA2) enzymes, catalysts of the PC-LPC metabolism [29], in GD and PD pathomechanism. This evidence concerns the gene PLA2G7 and Parkinson disease.